Pages that link to "Q37183587"
Jump to navigation
Jump to search
The following pages link to Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency (Q37183587):
Displaying 50 items.
- Disorders of carnitine transport and the carnitine cycle (Q24658342) (← links)
- Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily (Q27010565) (← links)
- Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome (Q28131828) (← links)
- Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter (Q28142569) (← links)
- A missense mutation in the OCTN2 gene associated with residual carnitine transport activity (Q28145027) (← links)
- Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency (Q28146135) (← links)
- Laboratory approach to mitochondrial diseases (Q28192185) (← links)
- Development and characterization of an animal model of carnitine deficiency (Q28204749) (← links)
- Genomic interval engineering of mice identifies a novel modulator of triglyceride production (Q28504607) (← links)
- Identification of human CDV-1R and mouse Cdv-1R, two novel proteins with putative signal peptides, especially highly expressed in testis and increased with the male sex maturation (Q28506427) (← links)
- Molecular and functional characterization of organic cation/carnitine transporter family in mice (Q28511892) (← links)
- beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter (Q28584010) (← links)
- Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters (Q28624134) (← links)
- Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research (Q30883430) (← links)
- Primary and secondary alterations of neonatal carnitine metabolism. (Q33637046) (← links)
- Xenobiotic, bile acid, and cholesterol transporters: function and regulation. (Q33714593) (← links)
- Mitochondrial disorders. A diagnostic challenge in clinical chemistry (Q33793717) (← links)
- The molecular diagnosis of metabolic myopathies (Q33829445) (← links)
- Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testing (Q33939558) (← links)
- Role of plasma membrane transporters in muscle metabolism. (Q33973728) (← links)
- Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening (Q34092807) (← links)
- The organic anion transporter family: from physiology to ontogeny and the clinic (Q34310328) (← links)
- Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response (Q34462269) (← links)
- Carnitine biosynthesis in mammals (Q34501779) (← links)
- Pharmacokinetics of L-carnitine (Q34536074) (← links)
- Disposition and metabolite kinetics of oral L-carnitine in humans (Q34567517) (← links)
- Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. (Q34617143) (← links)
- Role of carnitine in disease (Q34618777) (← links)
- Dialysis-related carnitine disorder and levocarnitine pharmacology (Q35128999) (← links)
- Carnitine transport: pathophysiology and metabolism of known molecular defects (Q35188329) (← links)
- Genotype-phenotype correlation in primary carnitine deficiency (Q35618853) (← links)
- SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE) (Q36154555) (← links)
- Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice (Q36319365) (← links)
- Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0, ) (Q36640736) (← links)
- Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. (Q36654675) (← links)
- Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications (Q36808739) (← links)
- Protective effect of l-carnitine against acrylamide-induced DNA damage in somatic and germ cells of mice (Q37062749) (← links)
- Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members (Q37265749) (← links)
- Primary carnitine deficiency and cardiomyopathy (Q37420074) (← links)
- Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects (Q38026944) (← links)
- Primary carnitine deficiency: novel mutations and insights into the cardiac phenotype (Q38078974) (← links)
- Renal transport of organic anions and cations (Q38111725) (← links)
- Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism (Q38183877) (← links)
- Disorders of carnitine biosynthesis and transport (Q38589269) (← links)
- Biochemical characteristics of newborns with carnitine transporter defect identified by newborn screening in California (Q38677553) (← links)
- The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations (Q38888345) (← links)
- Human OCTN2 (SLC22A5) is down-regulated in virus- and nonvirus-mediated cancer. (Q39388456) (← links)
- Significance of l-carnitine for human health. (Q39400152) (← links)
- Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. (Q39816980) (← links)
- Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid (Q40257897) (← links)